Long-term survival in multiple myeloma: a single-center experience
β Scribed by Francesca Merchionne; Pasquale Procaccio; Franco Dammacco
- Publisher
- Springer
- Year
- 2008
- Tongue
- English
- Weight
- 68 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0372-8722
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND. Bortezomib is active in heavily pretreated multiple myeloma patients; the doseβlimiting toxicity is peripheral neuropathy (PN). ## METHODS. The authors retrospectively reviewed the incidence, severity, and risk factors for PN in 78 patients who received bortezomib. The
## Abstract ## Background and Objectives Laparoscopyβassisted distal gastrectomy (LADG) has been established as an alternative treatment for early gastric cancer (EGC) because of excellent shortβterm results. However, only a few reports have considered the longβterm outcomes of LADG. In this study